These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12520728)

  • 1. [Methods for treating children with newly diagnosed idiopathic thrombocytopenic purpura--evidence versus opinion based medicine].
    Kühne T
    Praxis (Bern 1994); 2002 Dec; 91(50):2193-6. PubMed ID: 12520728
    [No Abstract]   [Full Text] [Related]  

  • 2. A review of anti-D treatment of childhood idiopathic thrombocytopenic purpura.
    Kjaersgaard M; Hasle H
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):717-20. PubMed ID: 16933265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autoimmune thrombocytopenia--a therapeutic challenge].
    Heimpel H
    Onkologie; 2010; 33 Suppl 3():1. PubMed ID: 20484948
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluating bleeding severity in children with newly diagnosed immune thrombocytopenia: a pilot study.
    Pansy J; Minkov M; Dengg R; Quehenberger F; Lackner H; Nebl A; Sovinz P; Schwinger W; Urban C; Benesch M
    Klin Padiatr; 2010 Nov; 222(6):374-7. PubMed ID: 21058224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute immune (idiopathic) thrombocytopenic purpura in childhood.
    Tarantino MD
    Blood Rev; 2002 Mar; 16(1):19-21. PubMed ID: 11913988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of chronic idiopathic thrombocytopenic purpura.
    ElAlfy M; Farid S; Abdel Maksoud A
    Pediatr Blood Cancer; 2010 Jul; 54(7):959-62. PubMed ID: 20405514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current options for the treatment of idiopathic thrombocytopenic purpura.
    Arnold DM; Kelton JG
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S12-23. PubMed ID: 18096468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the treatment of childhood immune thrombocytopenic purpura.
    Tarantino M
    Semin Hematol; 2006 Jul; 43(3 Suppl 5):S11-7; discussion S18-9. PubMed ID: 16815345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of outcomes and treatment costs for children undergoing splenectomy for chronic immune thrombocytopenia purpura.
    Gwilliam NR; Lazar DA; Brandt ML; Mahoney DH; Wesson DE; Mazziotti MV; Nuchtern JG; Lee TC
    J Pediatr Surg; 2012 Aug; 47(8):1537-41. PubMed ID: 22901913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune thrombocytopenic purpura: why treat?
    Nugent DJ
    J Pediatr; 1999 Jan; 134(1):3-4. PubMed ID: 9880438
    [No Abstract]   [Full Text] [Related]  

  • 11. [Primary immune thrombocytopenia].
    Wehrli M; Goede JS
    Praxis (Bern 1994); 2014 Apr; 103(9):485-94; quiz 495-6. PubMed ID: 24755495
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-D for the treatment of splenectomized patients with immune thrombocytopenic purpura.
    Cardo LJ; Strack M; Williams J
    Blood; 1991 Nov; 78(10):2786-7. PubMed ID: 1668611
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-D immunoglobulin in children with newly diagnosed immune thrombocytopenic purpura: a pilot study.
    Monteleone PM; Vander Heyden MA; Steele DA; Kelleher JF
    Haematologica; 2000 Aug; 85(8):887-8. PubMed ID: 10942950
    [No Abstract]   [Full Text] [Related]  

  • 14. [The current studies of the treatment of idiopathic thrombocytopenic purpura].
    Wang SH
    Zhonghua Nei Ke Za Zhi; 1992 Mar; 31(3):181-3. PubMed ID: 1327675
    [No Abstract]   [Full Text] [Related]  

  • 15. Does treatment of newly diagnosed idiopathic thrombocytopenic purpura reduce morbidity?
    Treutiger I; Rajantie J; Zeller B; Henter JI; Elinder G; Rosthøj S;
    Arch Dis Child; 2007 Aug; 92(8):704-7. PubMed ID: 17460024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, randomized trial of conventional, dose-accelerated corticosteroids and intravenous immunoglobulin in children with newly diagnosed idiopathic thrombocytopenic purpura.
    Fujisawa K; Iyori H; Ohkawa H; Konishi S; Bessho F; Shirahata A; Miyazaki S; Akatsuka J;
    Int J Hematol; 2000 Oct; 72(3):376-83. PubMed ID: 11185998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatigue as marker of thrombocytopenia in childhood idiopathic thrombocytopenic purpura.
    Blatt J; Weston B; Gold S
    Pediatr Hematol Oncol; 2010 Feb; 27(1):65-7. PubMed ID: 20121557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Durable response to a single dose of Anti D in immune thrombocytopenic purpura in an adult with underlying human immunodeficiency viral infection.
    Hewamana S; Pepper C; Karunanithi K; Jenkins C; Rowntree C
    Ann Hematol; 2009 Nov; 88(11):1155-6. PubMed ID: 19399500
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of newly diagnosed immune thrombocytopenia: can we change outcomes?
    Neunert CE
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):400-405. PubMed ID: 29222284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemorrhagic bullae in the oral mucosa with gingival bleeding.
    Rivera C; Torres Í; González-Arriagada WA
    BMJ; 2017 Oct; 359():j4476. PubMed ID: 29074642
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.